T
THC Farmaceuticals Inc
OTC:CBDG
THC Farmaceuticals Inc
OTC:CBDG
Price:
0.0182
USD
-60.43%
Market Closed
Market Cap:
$330k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
THC Farmaceuticals Inc
OTC:CBDG
|
US |
|
Definity Financial Corp
TSX:DFY
|
CA |
|
Amdocs Ltd
NASDAQ:DOX
|
US |
|
K
|
Kongsberg Gruppen ASA
OSE:KOG
|
NO |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of CBDG.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CBDG
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
CBDG Competitors Multiples
THC Farmaceuticals Inc Competitors
THC Farmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
T
|
THC Farmaceuticals Inc
OTC:CBDG
|
302.7k USD | 39.8 | -5 | -23.5 | -22.8 | |
| US |
|
Cintas Corp
NASDAQ:CTAS
|
67.5B USD | 6.3 | 35.7 | 23.3 | 28 | |
| US |
|
Copart Inc
NASDAQ:CPRT
|
31.8B USD | 6.9 | 20.4 | 14 | 15.9 | |
| AU |
|
Brambles Ltd
ASX:BXB
|
30.2B AUD | 3.1 | 22.2 | 16.4 | 16.4 | |
| US |
|
RB Global Inc
F:J1F
|
15.6B EUR | 4 | 47.8 | 16.5 | 27.3 | |
| CA |
|
Ritchie Bros Auctioneers Inc
TSX:RBA
|
25B CAD | 4.1 | 48.7 | 16.8 | 27.8 | |
| FR |
|
Spie SA
PAR:SPIE
|
7.4B EUR | 0.7 | 41.2 | 7.9 | 14.1 | |
| US |
|
Aurora Innovation Inc
NASDAQ:AUR
|
8.2B USD | 2 733.2 | -10 | -8 | -7.7 | |
| FR |
|
Elis SA
PAR:ELIS
|
5.7B EUR | 1.2 | 15.4 | 5.1 | 13.4 | |
| DK |
|
Iss A/S
CSE:ISS
|
37.7B DKK | 0.4 | 14.3 | 8.1 | 11.3 | |
| US |
I
|
IAA Inc
F:3NI
|
4.9B EUR | 2.8 | 19.8 | 12.8 | 16.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
